HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of liposome based antigen delivery systems for protection against Leishmania donovani.

Abstract
Liposomes have been widely exploited as antigen delivery systems for a variety of diseases including leishmaniasis. These vesicles can be prepared in various ways which may affect the immunogenicity of the encapsulated antigens. In this study we compared the vaccine potentiality of three cationic formulations with Leishmania donovani promastigote membrane antigens (LAg) and the best vesicle was evaluated for long-term protection against experimental visceral leishmaniasis. We immunized mice with LAg encapsulated in multilamellar vesicles (MLV), dehydration-rehydration vesicles (DRV) and reverse-phase evaporation vesicles (REV) and challenged them with parasites ten days after vaccination. LAg in MLV or DRV induced almost complete protection, while LAg alone or entrapped in REV exhibited partial resistance. Protection observed with antigen incorporated MLV or DRV was predominantly Th1 as evidenced by elicitation of significantly high DTH, IgG2a antibodies and IFN-gamma. MLV encapsulated LAg demonstrated durable cell-mediated immunity and mice challenged ten weeks after vaccination could also resist experimental challenge strongly. Field trials of L. donovani vaccine were unsatisfactory mainly due to lack of an appropriate adjuvant. Cationic MLV when used as adjuvant with protein antigens induced sustained Th1 immunity. Adjuvant potential of cationic MLV can be utilized to design subunit vaccines.
AuthorsSwati Bhowmick, Tuhina Mazumdar, Roma Sinha, Nahid Ali
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 141 Issue 2 Pg. 199-207 (Jan 25 2010) ISSN: 1873-4995 [Electronic] Netherlands
PMID19818373 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2009 Elsevier B.V. All rights reserved.
Chemical References
  • Antibodies, Protozoan
  • Antigens, Protozoan
  • Liposomes
  • Protozoan Vaccines
  • Interleukin-4
  • Interferon-gamma
Topics
  • Animals
  • Antibodies, Protozoan (blood)
  • Antigens, Protozoan (administration & dosage, chemistry, immunology)
  • Cells, Cultured
  • Chemistry, Pharmaceutical
  • Disease Models, Animal
  • Hypersensitivity, Delayed (immunology, parasitology)
  • Immunity, Cellular
  • Immunity, Humoral
  • Interferon-gamma (metabolism)
  • Interleukin-4 (metabolism)
  • Leishmania donovani (immunology)
  • Leishmaniasis, Visceral (immunology, parasitology, prevention & control)
  • Liposomes
  • Macrophages (immunology, parasitology)
  • Mice
  • Mice, Inbred BALB C
  • Protozoan Vaccines (administration & dosage, chemistry, immunology)
  • Th1 Cells (immunology, parasitology)
  • Time Factors
  • Vaccination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: